Materialise NV (MTLS) - Total Liabilities
Based on the latest financial reports, Materialise NV (MTLS) has total liabilities worth $162.93 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Materialise NV (MTLS) net asset momentum to track the company's year-over-year net asset growth rate.
Materialise NV - Total Liabilities Trend (2011–2025)
This chart illustrates how Materialise NV's total liabilities have evolved over time, based on quarterly financial data. See Materialise NV free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Materialise NV Competitors by Total Liabilities
The table below lists competitors of Materialise NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kits Eyecare Ltd
TO:KITS
|
Canada | CA$37.62 Million |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
China | CN¥982.98 Million |
|
Integrated Diagnostics Holdings PLC
LSE:IDHC
|
UK | $3.67 Billion |
|
KGI Securities (Thailand) Public Company Limited
BK:KGI
|
Thailand | ฿8.97 Billion |
|
MT Hoejgaard Holding A/S
CO:MTHH
|
Denmark | Dkr2.91 Billion |
|
EQT Holdings Ltd
AU:EQT
|
Australia | AU$207.09 Million |
|
Chengdu Shengbang Seals Co.Ltd.
SHE:301233
|
China | CN¥85.45 Million |
|
Qingdao Hi-Tech Moulds & Plastics Technology Co. Ltd.
SHE:301022
|
China | CN¥805.15 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Materialise NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Materialise NV.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Materialise NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Materialise NV (2011–2025)
The table below shows the annual total liabilities of Materialise NV from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $165.09 Million | +11.67% |
| 2024-12-31 | $147.84 Million | -7.62% |
| 2023-12-31 | $160.04 Million | -12.23% |
| 2022-12-31 | $182.33 Million | +0.83% |
| 2021-12-31 | $180.83 Million | -23.32% |
| 2020-12-31 | $235.83 Million | +1.68% |
| 2019-12-31 | $231.93 Million | +30.86% |
| 2018-12-31 | $177.24 Million | +10.76% |
| 2017-12-31 | $160.02 Million | +93.06% |
| 2016-12-31 | $82.89 Million | +35.48% |
| 2015-12-31 | $61.18 Million | +27.32% |
| 2014-12-31 | $48.05 Million | +26.61% |
| 2013-12-31 | $37.95 Million | +13.84% |
| 2012-12-31 | $33.34 Million | +24.53% |
| 2011-12-31 | $26.77 Million | -- |
About Materialise NV
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the funct… Read more